Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40GYJ | ISIN: US43906K2096 | Ticker-Symbol:
NASDAQ
05.11.24
15:30 Uhr
3,790 US-Dollar
+0,030
+0,80 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HOOKIPA PHARMA INC Chart 1 Jahr
5-Tage-Chart
HOOKIPA PHARMA INC 5-Tage-Chart

Aktuelle News zur HOOKIPA PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07:18HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market2
DoHOOKIPA Pharma Inc.: HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 20243
MiHOOKIPA commences HPV16+ cancer adjuvant care trial5
MiHOOKIPA Pharma Inc.: HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer48Study done in collaboration with Memorial Sloan Kettering and led by Dr. Winston Wong, Head and Neck Oncologist and Dr. Alan Ho, Chief of the Head and Neck Oncology Service IIT will evaluate eseba-vec...
► Artikel lesen
01.10.Hookipa Pharma stock hits 52-week low at $4.06 amid market challenges11
24.09.HOOKIPA präsentiert Daten zur KRAS-Krebsbehandlung17
24.09.HOOKIPA presents KRAS cancer treatment data7
24.09.HOOKIPA Pharma Inc.: HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset4
30.08.HOOKIPA appoints new Non-Executive Chair as two members exit4
30.08.HOOKIPA Pharma Inc.: HOOKIPA Pharma Announces Board of Directors Changes3
30.08.HOOKIPA Pharma Inc. - 8-K, Current Report3
28.08.HOOKIPA Pharma Inc.: HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference4
09.08.HOOKIPA Pharma GAAP EPS of -$1.52 misses by $0.05, revenue of $1.3M misses by $5.79M6
08.08.HOOKIPA Pharma Inc. - 10-Q, Quarterly Report2
08.08.HOOKIPA Pharma Inc.: HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights192New Leadership Appointments; Positive Clinical and Regulatory Reports for the Lead Product Candidate, HB-200 (eseba-vec); On track to initiate the Phase 2/3 "AVALON-1" study with eseba-vec in Q4 2024...
► Artikel lesen
08.08.HOOKIPA Pharma Inc. - 8-K, Current Report2
22.07.HOOKIPA Pharma Inc.: HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200403Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany is conducting a review of its business operations...
► Artikel lesen
10.07.HOOKIPA Pharma Inc. - 8-K, Current Report4
08.07.Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today7
08.07.Hookipa Pharma to execute 1-for-10 reverse stock split2
Seite:  Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1